InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

Surrozen, Inc.

SRZN Clue Score17
United States Fiscal year ends December CIK 0001824893 Results filed 20 Oct 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

76
Insider
Date
Role
Action
Shares
Price
Amount
TCG Crossover GP II, LLC
24 Mar 2026
10% owner
Buy indirect
53,329
$24.69
$1.32M
TCG Crossover GP II, LLC
24 Mar 2026
10% owner
Buy indirect
53,329
$24.69
$1.32M
TCG Crossover GP II, LLC
23 Mar 2026
10% owner
Buy indirect
7,611
$24.90
$189.51K
TCG Crossover GP II, LLC
23 Mar 2026
10% owner
Buy indirect
7,612
$24.90
$189.54K
TCG Crossover GP II, LLC
16 Mar 2026
10% owner
Buy indirect
595
$24.99
$14.87K
TCG Crossover GP II, LLC
16 Mar 2026
10% owner
Buy indirect
595
$24.99
$14.87K
TCG Crossover GP II, LLC
13 Mar 2026
10% owner
Buy indirect
17,716
$24.88
$440.72K
TCG Crossover GP II, LLC
13 Mar 2026
10% owner
Buy indirect
17,717
$24.88
$440.74K
TCG Crossover GP II, LLC
12 Mar 2026
10% owner
Buy indirect
6,187
$24.99
$154.58K
TCG Crossover GP II, LLC
12 Mar 2026
10% owner
Buy indirect
6,187
$24.99
$154.58K
TCG Crossover GP II, LLC
12 Feb 2026
10% owner
Buy indirect
546
$23.86
$13.03K
TCG Crossover GP II, LLC
12 Feb 2026
10% owner
Buy indirect
547
$23.86
$13.05K
TCG Crossover GP II, LLC
11 Feb 2026
10% owner
Buy indirect
8,881
$23.58
$209.37K
TCG Crossover GP II, LLC
11 Feb 2026
10% owner
Buy indirect
8,882
$23.58
$209.39K
TCG Crossover GP II, LLC
3 Feb 2026
10% owner
Buy indirect
2,177
$21.94
$47.76K
TCG Crossover GP II, LLC
3 Feb 2026
10% owner
Buy indirect
2,178
$21.94
$47.79K
TCG Crossover GP II, LLC
2 Feb 2026
10% owner
Buy indirect
365
$21.38
$7.80K
TCG Crossover GP II, LLC
2 Feb 2026
10% owner
Buy indirect
366
$21.38
$7.83K
TCG Crossover GP II, LLC
30 Jan 2026
10% owner
Buy indirect
2,135
$21.39
$45.67K
TCG Crossover GP II, LLC
30 Jan 2026
10% owner
Buy indirect
2,136
$21.39
$45.69K
Tim Kutzkey
20 Jan 2026
Director
Buy indirect
9,568
$19.60
$187.53K
Tim Kutzkey
20 Jan 2026
Director
Buy indirect
8,484
$19.60
$166.29K
Column Group III Gp, LP
20 Jan 2026
10% owner
Buy indirect
9,568
$19.60
$187.53K
Column Group III Gp, LP
20 Jan 2026
10% owner
Buy indirect
8,484
$19.60
$166.29K
Tim Kutzkey
16 Jan 2026
Director
Buy indirect
1,358
$20.00
$27.16K
Tim Kutzkey
16 Jan 2026
Director
Buy indirect
1,204
$20.00
$24.08K
Column Group III Gp, LP
16 Jan 2026
10% owner
Buy indirect
1,358
$20.00
$27.16K
Column Group III Gp, LP
16 Jan 2026
10% owner
Buy indirect
1,204
$20.00
$24.08K
Tim Kutzkey
15 Jan 2026
Director
Buy indirect
6,303
$19.89
$125.36K
Tim Kutzkey
15 Jan 2026
Director
Buy indirect
5,590
$19.89
$111.18K
Column Group III Gp, LP
15 Jan 2026
10% owner
Buy indirect
6,303
$19.89
$125.36K
Column Group III Gp, LP
15 Jan 2026
10% owner
Buy indirect
5,590
$19.89
$111.18K
Column Group III Gp, LP
14 Jan 2026
10% owner
Buy indirect
2,927
$19.99
$58.51K
Column Group III Gp, LP
14 Jan 2026
10% owner
Buy indirect
2,596
$19.99
$51.89K
Tim Kutzkey
14 Jan 2026
Director
Buy indirect
2,927
$19.99
$58.51K
Tim Kutzkey
14 Jan 2026
Director
Buy indirect
2,596
$19.99
$51.89K
Column Group III Gp, LP
13 Jan 2026
10% owner
Buy indirect
6,609
$19.80
$130.89K
Column Group III Gp, LP
13 Jan 2026
10% owner
Buy indirect
5,861
$19.80
$116.07K
Tim Kutzkey
13 Jan 2026
Director
Buy indirect
6,609
$19.80
$130.89K
Tim Kutzkey
13 Jan 2026
Director
Buy indirect
5,861
$19.80
$116.07K
Tim Kutzkey
6 Jan 2026
Director
Buy indirect
8,003
$19.89
$159.16K
Tim Kutzkey
6 Jan 2026
Director
Buy indirect
7,097
$19.89
$141.14K
Column Group III Gp, LP
6 Jan 2026
10% owner
Buy indirect
8,003
$19.89
$159.16K
Column Group III Gp, LP
6 Jan 2026
10% owner
Buy indirect
7,097
$19.89
$141.14K
Column Group III Gp, LP
5 Dec 2025
10% owner
Buy indirect
16,381
$19.54
$320.10K
Column Group III Gp, LP
5 Dec 2025
10% owner
Buy indirect
14,503
$19.54
$283.40K
Tim Kutzkey
5 Dec 2025
Director
Buy indirect
16,381
$19.54
$320.10K
Tim Kutzkey
5 Dec 2025
Director
Buy indirect
14,503
$19.54
$283.40K
Column Group III Gp, LP
4 Dec 2025
10% owner
Buy indirect
2,791
$17.35
$48.42K
Column Group III Gp, LP
4 Dec 2025
10% owner
Buy indirect
2,475
$17.35
$42.93K
Tim Kutzkey
4 Dec 2025
Director
Buy indirect
2,791
$17.35
$48.42K
Tim Kutzkey
4 Dec 2025
Director
Buy indirect
2,475
$17.35
$42.93K
Column Group III Gp, LP
13 Nov 2025
10% owner
Buy indirect
167,307
$12.65
$2.12M
Column Group III Gp, LP
13 Nov 2025
10% owner
Buy indirect
148,150
$12.65
$1.87M
Tim Kutzkey
13 Nov 2025
Director
Buy indirect
167,307
$12.65
$2.12M
Tim Kutzkey
13 Nov 2025
Director
Buy indirect
148,150
$12.65
$1.87M
Column Group III Gp, LP
26 Mar 2025
10% owner
Buy indirect
344,827
$11.60
$4.00M
Column Group III Gp, LP
26 Mar 2025
10% owner
Buy indirect
365,769
$11.60
$4.24M
Column Group III Gp, LP
26 Mar 2025
10% owner
Buy indirect
323,886
$11.60
$3.76M
Column Group III Gp, LP
4 Apr 2024
10% owner
Buy indirect
102,651
$15.50
$1.59M
Column Group III Gp, LP
4 Apr 2024
10% owner
Buy indirect
90,897
$15.50
$1.41M
Tim Kutzkey
4 Apr 2024
Director
Buy indirect
102,651
$15.50
$1.59M
Tim Kutzkey
4 Apr 2024
Director
Buy indirect
90,897
$15.50
$1.41M
Craig C Parker
4 Apr 2024
Chief Executive Officer
Buy
1,474
—
no price
Charles O Williams
4 Apr 2024
CFO and COO
Buy
1,474
—
no price
Kevin Harold Livingston
1 Dec 2020
Chief Financial Officer
Buy indirect
24,000
—
no price
Benny Soffer
1 Dec 2020
Director
Buy indirect
24,000
—
no price
Life Sciences Consonance
1 Dec 2020
10% owner
Buy
24,000
—
no price
Mitchell J Md Blutt
1 Dec 2020
Director
Buy indirect
24,000
—
no price
Benny Soffer
23 Nov 2020
Director
Buy indirect
410,000
—
no price
Life Sciences Consonance
23 Nov 2020
10% owner
Buy
410,000
—
no price
Mitchell J Md Blutt
23 Nov 2020
Director
Buy indirect
410,000
—
no price
Kevin Harold Livingston
23 Nov 2020
Chief Financial Officer
Buy indirect
410,000
—
no price
Mitchell J Md Blutt
23 Nov 2020
Director
Buy indirect
128,900
—
no price
Mitchell J Md Blutt
23 Nov 2020
Director
Buy indirect
371,100
—
no price
Mitchell J Md Blutt
23 Nov 2020
Director
Buy indirect
500,000
—
no price
Show all 95 transactions →

What was left out

Form 4 filings counted 144
Amendments (4/A) skipped 10
Filings about a different issuer 0
Unreadable filings 0
Joint filings 16
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 13
Transactions with no price 17
Shares from compensation/vesting 21,439,126
Sales filed before the plan box existed 4
History held since 25 Nov 2020